Optimising first- and second-line treatment strategies for untreated major depressive disorder — the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial

BACKGROUND: For patients starting treatment for depression, current guidelines recommend titrating the antidepressant dosage to the maximum of the licenced range if tolerated. When patients do not achieve remission within several weeks, recommendations include adding or switching to another antidepr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Tadashi, Furukawa, Toshi A., Mantani, Akio, Kurata, Ken’ichi, Kubouchi, Hajime, Hirota, Susumu, Sato, Hirotoshi, Sugishita, Kazuyuki, Chino, Bun, Itoh, Kahori, Ikeda, Yoshio, Shinagawa, Yoshihiro, Kondo, Masaki, Okamoto, Yasumasa, Fujita, Hirokazu, Suga, Motomu, Yasumoto, Shingo, Tsujino, Naohisa, Inoue, Takeshi, Fujise, Noboru, Akechi, Tatsuo, Yamada, Mitsuhiko, Shimodera, Shinji, Watanabe, Norio, Inagaki, Masatoshi, Miki, Kazuhira, Ogawa, Yusuke, Takeshima, Nozomi, Hayasaka, Yu, Tajika, Aran, Shinohara, Kiyomi, Yonemoto, Naohiro, Tanaka, Shiro, Zhou, Qi, Guyatt, Gordon H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040068/
https://www.ncbi.nlm.nih.gov/pubmed/29991347
http://dx.doi.org/10.1186/s12916-018-1096-5

Ejemplares similares

Ejemplares similares